Showing 1 - 20 results of 46,013 for search '(((( 5 we decrease ) OR ( 4 wt decrease ))) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 0.76s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…<i>n</i> = 4 oocytes for WT (pH IC<sub>50</sub> = 7.49 ± 0.016) and 5 oocytes for C456Y (pH IC<sub>50</sub> = 7.11 ± 0.0075), *<i>P</i> = 0.016, Mann-Whitney. …”
  5. 5
  6. 6

    Decreased virulence observed during <i>in planta</i> infection with <i>ΔFgknr4</i>. by Erika Kroll (20537020)

    Published 2025
    “…In wheat inoculated with <i>ΔFgknr4</i> compared to WT, decreased host colonisation is observed, evidenced by (i) reduced fungal hyphae proliferation, particularly in the thicker adaxial cell layer, (ii) collapsed air spaces in wheat cells, and (iii) increased polymer deposition at the wheat cell walls (black arrows), indicating an enhanced defence response. …”
  7. 7
  8. 8

    NatB-inactivation decreased Drk levels through its N-terminal sequences, which was regulated by the N-end rule E3 ubiquitin ligase POE/UBR4. by Zhentao Sheng (107495)

    Published 2020
    “…(C) Expression of WT Psid rescued the level of N-Drk-GFP in <i>psid-D4</i> mutant clones. …”
  9. 9
  10. 10

    NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

    Published 2020
    “…(C) <i>psid-D4</i> clones in wing disc, marked by GFP expression (pointed by arrowheads), showed decreased MAPK level. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    DataSheet4_Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.ZIP by Michael Horckmans (14206388)

    Published 2022
    “…The N178T variant is a loss-of-function mutation of the human P2Y<sub>4</sub> receptor and is encountered less frequently in coronary patients than in control individuals. …”
  17. 17

    GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

    Published 2021
    “…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
  18. 18
  19. 19
  20. 20